- Home
- YSG vs OSUR Comparison
YSG vs OSUR Comparison
Compare YSG & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YSG | OSUR |
|---|---|---|
| Founded | 2016 | 2000 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.3M | 254.5M |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | YSG | OSUR |
|---|---|---|
| Price | $2.43 | $4.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 65.7K | ★ 493.0K |
| Earning Date | 11-16-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | $4.74 | $6.16 |
| Revenue Next Year | $11.48 | $9.09 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.15 | $2.08 |
| 52 Week High | $7.74 | $4.58 |
Technical Indicators
Market Signals| Indicator | YSG | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 41.59 | 60.69 |
| Support Level | $2.38 | $3.67 |
| Resistance Level | $3.49 | $4.16 |
| Average True Range (ATR) | 0.13 | 0.18 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 17.39 | 88.03 |
Price Performance
Historical ComparisonAbout YSG Yatsen Holding Limited
Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands. Geographically, company operates in PRC, Europe and US regions.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.